IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus
Diabetes mellitus (DM) is a chronic disease that affects nowadays millions of people worldwide. In adults, type 2 diabetes mellitus (T2DM) accounts for the majority of all diagnosed cases of diabetes. The course of the T2DM is characterized by insulin resistance and a progressive loss of β-cell mass...
Saved in:
Main Authors: | Concepción Peiró (Author), Óscar Lorenzo (Author), Raffaele Carraro (Author), Carlos F. Sánchez-Ferrer (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Visfatin/PBEF/Nampt: a new cardiovascular target?
by: Concepción ePeiró, et al.
Published: (2010) -
DPP4 and ACE2 in Diabetes and COVID-19: Therapeutic Targets for Cardiovascular Complications?
by: Inés Valencia, et al.
Published: (2020) -
The angiotensin-(1-7)/Mas axis counteracts angiotensin II-dependent and -independent pro-inflammatory signaling in human vascular smooth muscle cells
by: Laura A Villalobos, et al.
Published: (2016) -
Visfatin/Nampt: An Adipokine with Cardiovascular Impact
by: Tania Romacho, et al.
Published: (2013) -
Nutrigenómica, obesidad y salud pública.
by: Manuela Belén Silveira, et al.
Published: (2007)